DOCSLIB.ORG

Microdialysis in Traumatic Brain Injury – Methodology and Pathophysiology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Microdialysis in Traumatic Brain Injury – Methodology and Pathophysiology Acta Neurochir (2005) [Suppl] 95: 441–445 6 Springer-Verlag 2005 Printed in Austria Microdialysis in traumatic brain injury – methodology and pathophysiology P. J. Hutchinson Academic Department of Neurosurgery and Wolfson Brain Imaging Centre, University of Cambridge, Addenbrooke’s Hospital, UK Summary ters and brain tissue oxygen sensors) is also widely practised both for research and clinical purposes [15]. The application of clinical microdialysis to monitor changes in ce- rebral extracellular chemistry is now well established in several neu- Measurement of the e¤ect of fundamental derange- rosurgical units worldwide. In neuro-intensive care the technique has ments of pathophysiology such as increased ICP, re- been predominantly applied to patients with traumatic brain injury duced CBF and reduced cerebral oxygenation in terms and subarachnoid haemorrhage. There is no doubt that microdialy- sis has increased and continues to increase our understanding of the of the impact on cerebral metabolism is now feasible pathophysiology of these conditions. Current studies are addressing with the application of cerebral microdialysis. This has the potential role of microdialysis as a clinical monitoring technique enabled monitoring of brain injury in terms of changes assisting in the management of patients on an intention to treat basis. in the extracellular concentration of fundamental sub- This involves establishing the relationship between microdialysis and outcome, and the e¤ect of therapeutic manoeuvres on the chemistry. strates and metabolites. This manuscript describes the place of microdialysis in traumatic The microdialysis technique was first described brain injury in terms of the fundamental principles, methodology, by Ungerstedt and Pycock in 1974 [29], applied to the pathophysiology and clinical application. human brain initially to monitor neurotransmitters Keywords: Traumatic brain injury; head injury; microdialysis; in Parkinson’s disease [20] and subsequently used to cerebral metabolism; hypoxia; ischemia. monitor patients with traumatic brain injury (TBI) and subarachnoid haemorrhage in neuro-intensive care. Introduction Following trauma to the head, one of the fundamen- Principle of microdialysis tal processes that results in progression of injury is cerebral ischemia. Both the primary insult (ictus) and The principle of cerebral microdialysis is the perfu- secondary insults such as hypoxia, hypotension and sion of a fine catheter lined with semi-permeable renal seizures contribute to this process. Ischemia results in dialysis membrane [28], introduced into the cerebral reduced oxygen delivery, energy failure, and cerebral cortex either directly or via a cranial access device. edema. One of the goals of traumatic brain injury The catheter comprises an inlet tube, a shaft, a mem- management is to detect and treat these secondary in- brane and an outlet tube. The inlet tube is perfused sults in order to reduce injury progression and improve with a physiological solution such as normal saline or outcome. Ringer’s solution at very low flow rates (typically 0.1– In neuro-intensive care, measurement of intra- 2.0 ml/min i.e. approximately 0.15–3.0 ml/day) using cranial pressure (ICP) is the cornerstone of multimo- a precision pump. The solution passes down the con- dality monitoring and is recommended by US and Eu- centric shaft to the membrane where molecules di¤use ropean guidelines [5, 16]. Monitoring of cerebral blood from the extracellular space into the perfusion fluid. flow (CBF; by extrapolation of flow velocity from The solution then passes up the shaft via the outlet trans-cranial Doppler or by functional imaging) and tube into collecting vials. Standard membranes have a brain oxygenation (by jugular venous oxygen cathe- 20 kDa cut-o¤ and are applied to measure the concen- 442 P. J. Hutchinson tration. The term ‘‘recovery’’ is applied to the propor- tion of substance in the extracellular fluid that is de- tected in the dialysate. ‘‘Relative recovery’’ depends on the length of the dialysis membrane, the rate of flow of the perfusion fluid, the speed of di¤usion of the substance and the properties of the membrane. Relative recovery is defined as concentration of a par- ticular substance in the fluid as it leaves the dialysis membrane expressed as a percentage of the concentra- tion in the extracellular fluid surrounding the mem- brane. It approaches 100% when the flow rate ap- Fig. 1. Fundamental substrates and metabolites monitored by proaches zero. Absolute recovery is the total amount microdialysis. Glucose is metabolised to pyruvate (glycolysis) which of substance recovered during a defined time period, enters the citric acid cycle. However, under conditions of hypoxia, pyruvate is preferentially metabolised to lactate. The lactate/ usually the sampling period. It approaches a maxi- pyruvate ratio is therefore a marker of anaerobic metabolism. Gluta- mum value at higher flow rates because the concentra- mate and glycerol are also markers of evolving injury tion gradients between the environment of perfusate/ dialysate are then maximal. In practice, long mem- branes (10–30 mm) and slow flow rates (0.3–2 ml/ min) are used to increase recovery rates. Longer tration of glucose as an indicator of glucose supply and 30 mm membranes enable significantly higher re- uptake, the lactate/pyruvate ratio as an indicator of covery rates than shorter 10 mm membranes but are anaerobic metabolism, glutamate as a marker of exci- more di‰cult to implant and may monitor heteroge- totoxicity and the release of glycerol from damaged neous volumes of brain. Slow flow rates while increas- cell membranes (Fig. 1). Molecular cut-o¤ membranes ing recovery, reduce the volume of dialysate available of 100 kDa can also be applied which enable the detec- for analysis in a given unit time. tion of larger proteins. The collecting vials are changed The concept of recovery can be applied to determine at set intervals of 10–60 minutes and analysed for glu- the true extracellular concentration of a particular sub- cose, pyruvate, lactate and glutamate at the bedside us- stance by varying the flow rate, while measuring the ing automated enzyme analysers and then stored for changes in concentration of substance coming out of delayed o¤-line analysis using, for example HPLC, to the catheter, and extrapolating to zero flow. Using this detect other amino acids. technique the relative recovery for the 10 mm 20 kDa cut-o¤ CMA70 catheter has been shown to be approx- imately 70% at 0.3 ml/min and 30% at 1.0 ml/min for Methodology of microdialysis glucose, pyruvate, lactate and glutamate [12]. There are a number of important considerations to be taken into account in terms of the clinical appli- Perfusion fluid cation of microdialysis to the human brain. These in- Ideally, the composition of the perfusion fluid should clude the concepts of recovery, the choice of perfusion be as close to the normal physiological values of the fluid, and critical appraisal of the technique. extracellular fluid. Early clinical microdialysis studies utilised normal saline. However, concerns raised from animal studies that depletion of calcium will impair Recovery neurotransmitter release have lead to introduction of The microdialysis catheter lies within the extracellu- other solutions such as CMA perfusion fluid. Despite lar space mimicking a blood vessel allowing communi- these concerns the absence of calcium from the perfu- cation with the extracellular fluid along a logarithmic sate does not appear to a¤ect the recovery of glucose, concentration gradient towards and away from the lactate, pyruvate and glutamate [12]. For the larger catheter. It is important to recognise, therefore that cut-o¤ molecular membranes it is recommended that the level of substance detected in the dialysis fluid does dextran is added to the perfusion fluid to maintain di- not necessarily equate to the true extracellular concen- alysate volume. Microdialysis in traumatic brain injury – methodology and pathophysiology 443 Critical appraisal sion of the extracellular space in vasogenic oe- dema will potentially lead to a lower tortuosity There are a number of points which require critical factor (i.e. ease of passage of molecules through evaluation in terms of the application of clinical cere- the extracellular fluid) and hence a higher di¤u- bral microdialysis. sion coe‰cient than in normal brain. (i) Microdialysis-induced tissue trauma. Animal (iii) The origin of neurotransmitters needs to be estab- studies have raised concerns regarding tissue trau- lished. It is important to determine whether neu- ma induced by catheter insertion. There is evi- rotransmitters detected in the dialysate reflect true dence of uncoupling of regional cerebral blood synaptic release or non-specific overflow from flow from local brain glucose metabolism for the synaptic and non-synaptic sources [27]. Currently first 24 hours after probe insertion which is [2, 4] the smallest catheters available are about 200 mm probably a consequence of relative size of the mi- external diameter. The synaptic cleft is approxi- crodialysis catheter. Other animal studies have mately 0.02 mm across. Consequently, it is not shown reticular fibre deposition and gliosis after possible to monitor neurotransmitter release in several days which is likely to be a consequence this region. However, evidence suggests that of lack of sterility of the catheter [3]. These factors many systems function via overflow mechanisms must be considered in the design of studies and in- as well as classic vesicular release from the pre- terpretation of the results. However, the recovery synaptic membrane, di¤usion across the synaptic rates of substances stabilise after 30 minutes, his- cleft and binding to post-synaptic membrane tological studies show only occasional microhae- receptors. morrhages [3] and the blood brain barrier remains intact [18]. Post-mortem studies in sheep and hu- Pathophysiology of traumatic brain injury man brains have revealed minimal or no distur- bance to the cerebral parenchyma as a result of There is now increasing experience of microdialysis microdialysis catheter implantation [13, 31]. in patients with severe traumatic brain injury.
Load more

Recommended publications
  • Microdialysis of Dopamine Interpreted with Quantitative Model Incorporating Probe Implantation Trauma
    Journal of Neurochemistry, 2003, 86, 932–946 doi:10.1046/j.1471-4159.2003.01904.x Microdialysis of dopamine interpreted with quantitative model incorporating probe implantation trauma Peter M. Bungay,* Paige Newton-Vinson, Wanda Isele,* Paul A. Garrisà and Joseph B. Justice, Jr *Division of Bioengineering & Physical Science, National Institutes of Health, DHHS, Bethesda, Maryland, USA Department of Chemistry, Emory University, Atlanta, Georgia, USA àDepartment of Biological Science, Illinois State University, Normal, Illinois, USA Abstract identified by histology and proposed to distort measurements Although microdialysis is widely used to sample endogenous of extracellular DA levels by the no-net-flux method. To and exogenous substances in vivo, interpretation of the address this issue, an existing quantitative mathematical results obtained by this technique remains controversial. The model for microdialysis was modified to incorporate a trau- goal of the present study was to examine recent criticism of matized tissue layer interposed between the probe and sur- microdialysis in the specific case of dopamine (DA) meas- rounding normal tissue. The tissue layers are hypothesized to urements in the brain extracellular microenvironment. The differ in their rates of neurotransmitter release and uptake. A apparent steady-state basal extracellular concentration and post-implantation traumatized layer with reduced uptake and extraction fraction of DA were determined in anesthetized rat no release can reconcile the discrepancy between DA uptake striatum by the concentration difference (no-net-flux) micro- measured by microdialysis and voltammetry. The model pre- dialysis technique. A rate constant for extracellular clearance dicts that this trauma layer would cause the DA extraction of DA calculated from the extraction fraction was smaller than fraction obtained from microdialysis in vivo calibration tech- the previously determined estimate by fast-scan cyclic vol- niques, such as no-net-flux, to differ from the DA relative tammetry for cellular uptake of DA.
    [Show full text]
  • Increases in GABA Concentrations During Cerebral Ischaemia: A
    J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.72.1.99 on 1 January 2002. Downloaded from 99 PAPER Increases in GABA concentrations during cerebral ischaemia: a microdialysis study of extracellular amino acids P J Hutchinson, M T O’Connell, P G Al-Rawi, C R Kett-White, A K Gupta, L B Maskell, J D Pickard, P J Kirkpatrick ............................................................................................................................. J Neurol Neurosurg Psychiatry 2002;72:99–105 Objectives: Increases in the extracellular concentration of the excitatory amino acids glutamate and aspartate during cerebral ischaemia in patients are well recognised. Less emphasis has been placed on the concentrations of the inhibitory amino acid neurotransmitters, notably γ-amino-butyric acid (GABA), despite evidence from animal studies that GABA may act as a neuroprotectant in models of See end of article for ischaemia. The objective of this study was to investigate the concentrations of various excitatory, inhibi- authors’ affiliations ....................... tory and non-transmitter amino acids under basal conditions and during periods of cerebral ischaemia in patients with head injury or a subarachnoid haemorrhage. Correspondence to: Methods: Cerebral microdialysis was established in 12 patients with head injury (n=7) or subarach- Mr PJ Hutchinson, Academic Department of noid haemorrhage (n=5). Analysis was performed using high performance liquid chromatography for Neurosurgery, University of a total of 19 (excitatory, inhibitory and non-transmitter) amino acids. Patients were monitored in neu- Cambridge, Box 167, rointensive care or during aneurysm clipping. Addenbrooke’s Hospital, Results: During stable periods of monitoring the concentrations of amino acids were relatively constant Cambridge CB2 2QQ, UK; enabling basal values to be established.
    [Show full text]
  • The Origin and Neuronal Function of in Vivo Nonsynaptic Glutamate
    The Journal of Neuroscience, October 15, 2002, 22(20):9134–9141 The Origin and Neuronal Function of In Vivo Nonsynaptic Glutamate David A. Baker, Zheng-Xiong Xi, Hui Shen, Chad J. Swanson, and Peter W. Kalivas Department of Physiology and Neuroscience, Medical University of South Carolina, Charleston, South Carolina 29425 Basal extracellular glutamate sampled in vivo is present in Infusion of the mGluR2/3 antagonist (RS)-1-amino-5- micromolar concentrations in the extracellular space outside phosphonoindan-1-carboxylic acid (APICA) increased extracel- the synaptic cleft, and neither the origin nor the function of this lular glutamate levels, and previous blockade of the antiporter glutamate is known. This report reveals that blockade of gluta- prevented the APICA-induced rise in extracellular glutamate. mate release from the cystine–glutamate antiporter produced a This suggests that glutamate released from the antiporter is a significant decrease (60%) in extrasynaptic glutamate levels in source of endogenous tone on mGluR2/3. Blockade of the the rat striatum, whereas blockade of voltage-dependent Na ϩ antiporter also produced an increase in extracellular dopamine and Ca 2ϩ channels produced relatively minimal changes (0– that was reversed by infusing the mGluR2/3 agonist (2R,4R)-4- 30%). This indicates that the primary origin of in vivo extrasyn- aminopyrrolidine-2,4-dicarboxlylate, indicating that antiporter- aptic glutamate in the striatum arises from nonvesicular gluta- derived glutamate can modulate dopamine transmission via mate
    [Show full text]
  • Regional Differences in Extracellular Dopamine and Serotonin Assessed by in Vivo Microdialysis in Mice Lacking Dopamine And/Or Serotonin Transporters
    Neuropsychopharmacology (2004) 29, 1790–1799 & 2004 Nature Publishing Group All rights reserved 0893-133X/04 $30.00 www.neuropsychopharmacology.org Regional Differences in Extracellular Dopamine and Serotonin Assessed by In Vivo Microdialysis in Mice Lacking Dopamine and/or Serotonin Transporters 1 1 1 1 1 Hao-wei Shen , Yoko Hagino , Hideaki Kobayashi , Keiko Shinohara-Tanaka , Kazutaka Ikeda , 1 2 3 4 5 Hideko Yamamoto , Toshifumi Yamamoto , Klaus-Peter Lesch , Dennis L Murphy , F Scott Hall , 5 ,1,5,6 George R Uhl and Ichiro Sora* 1 2 Department of Molecular Psychiatry, Tokyo Institute of Psychiatry, Japan; Laboratory of Molecular Recognition, Graduate School of Integrated 3 4 Science, Yokohama City University, Japan; Department of Psychiatry and Psychotherapy, University of Wurzburg, Germany; Laboratory of Clinical Science, Intramural Research Program, National Institute of Mental Health, USA; 5Molecular Neurobiology Branch, Intramural Research Program, National Institute on Drug Abuse, USA; 6Division of Psychobiology, Department of Neuroscience, Tohoku University Graduate School of Medicine, Japan Cocaine conditioned place preference (CPP) is intact in dopamine transporter (DAT) knockout (KO) mice and enhanced in serotonin transporter (SERT) KO mice. However, cocaine CPP is eliminated in double-KO mice with no DAT and either no or one SERT gene copy. To help determine mechanisms underlying these effects, we now report examination of baselines and drug-induced changes of extracellular dopamine (DA ) and serotonin (5-HT ) levels in microdialysates from nucleus accumbens (NAc), caudate putamen ex ex (CPu), and prefrontal cortex (PFc) of wild-type, homozygous DAT- or SERT-KO and heterozygous or homozygous DAT/SERT double- KO mice, which are differentially rewarded by cocaine.
    [Show full text]
  • Cerebral Microdialysis in Traumatic Brain Injury and Subarachnoid Hemorrhage: State of the Art
    Neurocrit Care (2014) 21:152–162 DOI 10.1007/s12028-013-9884-4 ESSENTIALS AND BASICS Cerebral Microdialysis in Traumatic Brain Injury and Subarachnoid Hemorrhage: State of the Art Marcelo de Lima Oliveira • Ana Carolina Kairalla • Erich Talamoni Fonoff • Raquel Chacon Ruiz Martinez • Manoel Jacobsen Teixeira • Edson Bor-Seng-Shu Published online: 26 September 2013 Ó Springer Science+Business Media New York 2013 Abstract Cerebral microdialysis (CMD) is a laboratory Introduction tool that provides on-line analysis of brain biochemistry via a thin, fenestrated, double-lumen dialysis catheter that is Cerebral microdialysis (CMD) is a well-established labo- inserted into the interstitium of the brain. A solute is slowly ratory tool that provides on-line analysis of the brain infused into the catheter at a constant velocity. The fen- biochemistry via a thin fenestrated dialysis catheter that is estrated membranes at the tip of the catheter permit free inserted into interstitium of the brain [1, 2]. Prior to the diffusion of molecules between the brain interstitium and development of CMD in 1970 [1], dextran-filled sacks the perfusate, which is subsequently collected for labora- were inserted into the brains of dogs and the fluid contained tory analysis. The major molecules studied using this there was studied afterwards. The first publication using method are glucose, lactate, pyruvate, glutamate, and microdialysis in humans was a 1987 study investigating glycerol. The collected substances provide insight into the interstitial glucose in adipose tissue. CMD has been used to neurochemical features of secondary injury following study the human brain since 1990, and it has been used in traumatic brain injury (TBI) and subarachnoid hemorrhage neurosurgical intensive care since 1992 [3].
    [Show full text]
  • Norepinephrine in the Prefrontal Cortex Is Critical for Amphetamine-Induced Reward and Mesoaccumbens Dopamine Release
    The Journal of Neuroscience, March 1, 2003 • 23(5):1879–1885 • 1879 Norepinephrine in the Prefrontal Cortex Is Critical for Amphetamine-Induced Reward and Mesoaccumbens Dopamine Release Rossella Ventura,1,2 Simona Cabib,1,2,3 Antonio Alcaro,1,2 Cristina Orsini,1,2 and Stefano Puglisi-Allegra1,2 1Dipartimento di Psicologia, Universita` “La Sapienza,” 00185 Rome, Italy, 2Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Santa Lucia, 00179 Rome, Italy, and 3Istituto di Psicobiologia e Psicofarmacologia, Consiglio Nazionale delle Ricerche, 00137 Rome, Italy Increasing evidence points to a major involvement of cortical areas in addictive mechanisms. Noradrenergic transmission in the medial prefrontal cortex (mpFC) has been shown to affect the motor effects of amphetamine, although there is no evidence of its involvement in the rewarding effects of this psychostimulant. The present experiments were aimed at investigating the possibility of a selective involvement of prefrontal cortical norepinephrine (NE) in the rewarding–reinforcing effects of amphetamine. To do so, we evaluated the effects of mpFC NE selective depletion in mice of C57BL/6J inbred strain, a background commonly used in molecular approaches that is known to be highly susceptible to the rewarding effects of the psychostimulant. In a first set of experiments, we demonstrated the absence of amphetamine-induced conditioned place preference in mice bearing prefrontal NE depletion. In a second series of experiments, we demonstrated that the same lesion dramatically reduced amphetamine-induced mesoaccumbens dopamine release as measured by intracerebral microdialysis. These results indicate that noradrenergic prefrontal transmission, by allowing increased dopamine release in the nucleus accumbens induced by amphetamine, is a critical factor for the rewarding–reinforcing effects of this drug.
    [Show full text]
  • A Review of Neurotransmitters Sensing Methods for Neuro-Engineering Research
    applied sciences Review A Review of Neurotransmitters Sensing Methods for Neuro-Engineering Research Shimwe Dominique Niyonambaza 1,2, Praveen Kumar 1, Paul Xing 3, Jessy Mathault 1, Paul De Koninck 1,4, Elodie Boisselier 2,5 , Mounir Boukadoum 6 and Amine Miled 1,* 1 LABioTRON Bioeng. Research Laboratory, ECE Dept. Université Laval, Québec City, QC G1V 0A6, Canada; [email protected] (S.D.N.); [email protected] (P.K.); [email protected] (J.M.); [email protected] (P.D.K.) 2 CUO-Recherche, Hôpital du Saint-Sacrement, Québec City, QC G3K 1A3, Canada; [email protected] 3 Neurosciences Dept. University of Montreal, Montreal, QC H3C 3J7, Canada; [email protected] 4 CERVO Brain Research Center, Québec City, QC G1J 2G3, Canada 5 Ophthalmology Department, Faculty of Medicine, Université Laval, Québec City, QC G1V 0A6, Canada 6 CoFaMic, Université du Québec à Montréal, Montreal, QC H2L 2C4, Canada; [email protected] * Correspondence: [email protected]; Tel.: +1-(418)-656-2131 (ext. 8966) Received: 1 May 2019; Accepted: 11 October 2019; Published: 5 November 2019 Abstract: Neurotransmitters as electrochemical signaling molecules are essential for proper brain function and their dysfunction is involved in several mental disorders. Therefore, the accurate detection and monitoring of these substances are crucial in brain studies. Neurotransmitters are present in the nervous system at very low concentrations, and they mixed with many other biochemical molecules and minerals, thus making their selective detection and measurement difficult. Although numerous techniques to do so have been proposed in the literature, neurotransmitter monitoring in the brain is still a challenge and the subject of ongoing research.
    [Show full text]
  • The Effect of Microdialysis Catheter Insertion on Glutamate And
    diagnostics Article The Effect of Microdialysis Catheter Insertion on Glutamate and Serotonin Levels in Masseter Muscle in Patients with Myofascial Temporomandibular Disorders and Healthy Controls Ermira Bajramaj 1, Birgitta Häggman-Henrikson 1,2 , Andreas Dawson 3,4, Björn Gerdle 4 and Bijar Ghafouri 4,* 1 Department of Orofacial Pain and Jaw Function, Faculty of Odontology, Malmö University, 205 06 Malmö, Sweden; [email protected] (E.B.); [email protected] (B.H.-H.) 2 Department of Odontology, Clinical Oral Physiology, Umeå University, 901 87 Umeå, Sweden 3 Centre for Oral Rehabilitation, Östergötland County Council, Linköping, 581 85 Norrköping, Sweden; [email protected] 4 Pain and Rehabilitation Centre, and Department of Medical and Health Sciences, Linköping University, 581 85 Linköping, Sweden; [email protected] * Correspondence: [email protected]; Tel.: +46-101032381 Received: 5 December 2018; Accepted: 19 January 2019; Published: 22 January 2019 Abstract: Myofascial temporomandibular disorders (TMD) are the most common cause of chronic pain in the orofacial region. Microdialysis has been used to study metabolic changes in the human masseter muscle. The insertion of the microdialysis probe causes acute tissue trauma that could affect the metabolic milieu and thereby influence the results when comparing healthy subjects to those with TMD. This study aimed to investigate the levels of serotonin and glutamate during the acute tissue trauma period in healthy subjects and in patients with TMD. Microdialysis was carried out in 15 patients with TMD and 15 controls, and samples were collected every 20 min during a period of 140 min. No significant alterations of serotonin or glutamate were observed over the 2 h period for the healthy subjects.
    [Show full text]
  • Effects of Systemic Glycine on Accumbal Glycine and Dopamine
    Journal of Neural Transmission (2021) 128:83–94 https://doi.org/10.1007/s00702-020-02284-x PSYCHIATRY AND PRECLINICAL PSYCHIATRIC STUDIES - ORIGINAL ARTICLE Efects of systemic glycine on accumbal glycine and dopamine levels and ethanol intake in male Wistar rats Yasmin Olsson1,2,3 · Helga Höifödt Lidö1,2 · Klara Danielsson1 · Mia Ericson1 · Bo Söderpalm1,2 Received: 19 September 2020 / Accepted: 28 November 2020 / Published online: 22 December 2020 © The Author(s) 2020 Abstract Approved medications for alcohol use disorder (AUD) display modest effect sizes. Pharmacotherapy aimed at the mechanism(s) by which ethanol activates the dopamine reward pathway may ofer improved outcomes. Basal and ethanol- induced accumbal dopamine release in the rat involve glycine receptors (GlyR) in the nucleus accumbens (nAc). Glycine transporter 1 (GlyT-1) inhibitors, which raise extracellular glycine levels, have repeatedly been shown to decrease ethanol intake in the rat. To further explore the rational for elevating glycine levels in the treatment of AUD, this study examined accumbal extracellular glycine and dopamine levels and voluntary ethanol intake and preference in the rat, after systemic treatment with glycine. The efects of three diferent doses of glycine i.p. on accumbal glycine and dopamine levels were examined using in vivo microdialysis in Wistar rats. In addition, the efects of the intermediate dose of glycine on voluntary ethanol intake and preference were examined in a limited access two-bottle ethanol/water model in the rat. Systemic glycine treatment increased accumbal glycine levels in a dose-related manner, whereas accumbal dopamine levels were elevated in a subpopulation of animals, defned as dopamine responders.
    [Show full text]
  • An Experiment and a Systematic Review of Histamine and Several Amino Acids Cathalijn H
    -2851$/2) Leenaars, CHC, et al. 2019 Sleep and Microdialysis: An Experiment and &,5&$',$15+<7+06 a Systematic Review of Histamine and Several Amino Acids. Journal of Circadian Rhythms, 17(1): 7, pp. 1–12. DOI: https://doi.org/10.5334/jcr.183 RESEARCH ARTICLE Sleep and Microdialysis: An Experiment and a Systematic Review of Histamine and Several Amino Acids Cathalijn H. C. Leenaars*,†,‡, W. H. Pim Drinkenburg§, Christ Nolten§, Maurice Dematteis‖, Ruud N. J. M. A. Joosten¶, Matthijs G. P. Feenstra¶ and Rob B. M. De Vries* Sleep seems essential to proper functioning of the prefrontal cortex (PFC). The role of different neurotransmitters has been studied, mainly the catecholamines and serotonin. Less attention has been paid to the amino acid transmitters and histamine. Here, we focus on the activity of these molecules in the PFC during sleep and sleep deprivation (SD). We determined extracellular concentrations of histamine and 8 amino acids in the medial PFC before, during and after SD. Additionally, we systematically reviewed the literature on studies reporting microdialysis measurements relating to sleep throughout the brain. In our experiment, median concentrations of glutamate were higher during SD than during baseline (p = 0.013) and higher during the dark-active than during the resting phase (p = 0.003). Glutamine was higher during post-SD recovery than during baseline (p = 0.010). For other compounds, no differences were observed between light and dark circadian phase, and between sleep deprivation, recovery and baseline. We retrieved 13 papers reporting on one or more of the molecules of interest during naturally occurring sleep, 2 during sleep deprivation and 2 during both.
    [Show full text]
  • Repeated Cocaine Injections Have No Influence on Tyrosine Hydroxylase Activity in the Rat Nucleus Accumbens Core Or Shell
    Brain Research 1012 (2004) 119–126 www.elsevier.com/locate/brainres Research report Repeated cocaine injections have no influence on tyrosine hydroxylase activity in the rat nucleus accumbens core or shell Stephanie C. Licataa,*, R. Christopher Piercea,b a Laboratory of Neuropsychopharmacology, Department of Pharmacology, Boston University School of Medicine, Boston, MA 02118, USA b Laboratory of Neuropsychopharmacology, Department of Psychiatry, Boston University School of Medicine, Boston, MA 02118, USA Accepted 31 March 2004 Available online 10 May 2004 Abstract Numerous reports have demonstrated augmented cocaine-evoked release of dopamine in the nucleus accumbens of rats pre-treated with cocaine. However, the extent to which repeated cocaine injections affect basal levels of dopamine is unclear. There have been reports of increases, decreases, or no change in basal levels of extracellular accumbal dopamine resulting from repeated psychostimulant administration. The present study assessed the activity of tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis, in the nucleus accumbens following either acute or repeated cocaine administration. The in vivo microdialysis technique was used to measure accumulation of the dopamine precursor DOPA following intra-accumbal administration of the DOPA decarboxylase inhibitor NSD 1015 through the microdialysis probe. This method provides an estimate of tyrosine hydroxylase activity within the nucleus accumbens. Results indicate that neither acute nor repeated cocaine administration produced any change in DOPA accumulation in either the nucleus accumbens shell or core. These data indicate that dopamine synthesis is not altered by cocaine administration. D 2004 Elsevier B.V. All rights reserved. Theme: Neural basis of behavior Topic: Drugs of abuse: cocaine Keywords: Cocaine; Microdialysis; DOPA; Tyrosine hydroxylase; Nucleus accumbens; Rat 1.
    [Show full text]
  • In Vivo Cerebral Microdialysis Validation of the Acute Central Glutamate Response in a Translational Rat Model of Concussion Combining Force and Rotation
    bioRxiv preprint doi: https://doi.org/10.1101/432633; this version posted October 1, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Running Title: Cerebral microdialysis and concussion combined model Title: In vivo cerebral microdialysis validation of the acute central glutamate response in a translational rat model of concussion combining force and rotation. Authors: Ian Massé PhD1, Luc Moquin2, Chloé Provost1, Samuel Guay1, Alain Gratton2, and Dr Louis De Beaumont PhD1. Affiliations: 1Research Center, Hôpital du Sacré-Cœur de Montréal, 5400 Gouin Ouest Blvd, Montreal, Quebec, Canada, H4J 1C5 2Research Center, Douglas Institute, 6875 LaSalle Blvd, Montreal, Quebec, Canada, H4H 1R3 Number of pages: 28 Number of figures: 9 Number of tables: 3 Number of equations: 0 Total number of words: 6081 Number of words in abstract: 335 Keywords: mild traumatic brain injury; concussion; head acceleration; cerebral microdialysis; rat Abbreviations: TBI = traumatic brain injury; mTBI = mild traumatic brain injury; ECF = extracellular fluid; CCI = controlled cortical impact; FPI = fluid percussion injury Corresponding author: Dr Louis De Beaumont PhD Centre de recherche Hôpital du Sacré-Cœur de Montréal 5400, boulevard Gouin Ouest Montréal, Québec H4J 1C5 Phone: 514-338-2222 ext 7722 FAX: 514 338-2694 E-mail address: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/432633; this version posted October 1, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]